Patents by Inventor Steven Minh Dinh

Steven Minh Dinh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TTS containing an antioxidant
    Patent number: 6335031
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: January 1, 2002
    Assignees: Novartis AG, LTS Lohmann Therapie-Systeme GmbH Co. KG
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Köpke, Henricus L. G. M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • TTS containing an antioxidant
    Publication number: 20010048938
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Application
    Filed: December 20, 2000
    Publication date: December 6, 2001
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Kopke, Henricus L.G.M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • TTS containing an antioxidant
    Patent number: 6316023
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an antioxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: November 13, 2001
    Assignees: Novartis AG, LTS Lohmann Therapie-Systeme GmbH
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Köpke, Henricus L. G. M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • Temporally controlled drug delivery systems
    Patent number: 6068853
    Abstract: A delivery mechanism and device for the passive periodic release of a drug or an active ingredient which avoids the need for external power sources and/or electronic controllers. By taking advantage of oscillating chemical systems, one can change the state, i.e. the pH, of a solution, a drug, enhancer or solubilizer resulting in oscillating the ability of an active ingredient to be delivered transdermally. The pH of a solution can be oscillated over a range of pH values from 2 to 10 by the reduction and oxidation (redox) reactions of salts, such as permanganates, iodates, sulfates, chlorates, or bromates. Upon activation, the delivery system conditions begin to oscillate and with it, the delivery of the active agent oscillates.
    Type: Grant
    Filed: October 13, 1995
    Date of Patent: May 30, 2000
    Assignee: Novartis Corporation
    Inventors: Steven Andrew Giannos, Steven Minh Dinh, Bret Berner
  • Iontophoretic transdermal delivery and control of adverse side-effects
    Patent number: 6018679
    Abstract: A method is disclosed for iontophoretically removing any compound that is capable of causing skin irritation or other harmful effects. More specifically, a bipolar iontophoretic transdermal delivery method is disclosed that includes a reversal phase for controlling the iontophoretic transdermal delivery of pharmaceutical compounds while reducing or eliminating skin irritation and terminating the pharmacological or toxicological effects in skin of drugs/cosmetics/active ingredients which form a drug depot in the skin after passive or iontophoretic application.
    Type: Grant
    Filed: January 29, 1997
    Date of Patent: January 25, 2000
    Assignee: Novartis Finance Corp.
    Inventors: Steven Minh Dinh, Parminder Bobby Singh, Ann Reese Comfort